fluphenazine has been researched along with Delusional Disorder in 51 studies
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On one of our rehabilitation wards, we observed several schizophrenic patients with therapy resistant hallucinations to exhibit complete recovery after being given fluphenazine (2-7." | 7.69 | [Is there a special indication for fluphenazine in therapy refractory hallucinations?]. ( Bechter, K, 1994) |
| "A mild form of neuroleptic malignant syndrome (NMS) in a schizophrenic patient who was receiving a depot neuroleptic is described and beneficial response to oral diazepam 50 mg daily is reported." | 7.67 | Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP, 1988) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 7.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| "/day) versus fixed standard dosage (20 mg." | 6.64 | High vs standard dosage fluphenazine HCL in acute schizophrenia. ( Donlon, PT; Meadow, A; Tupin, JP; Wahba, M, 1978) |
| "On one of our rehabilitation wards, we observed several schizophrenic patients with therapy resistant hallucinations to exhibit complete recovery after being given fluphenazine (2-7." | 3.69 | [Is there a special indication for fluphenazine in therapy refractory hallucinations?]. ( Bechter, K, 1994) |
| "A mild form of neuroleptic malignant syndrome (NMS) in a schizophrenic patient who was receiving a depot neuroleptic is described and beneficial response to oral diazepam 50 mg daily is reported." | 3.67 | Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP, 1988) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 3.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| " A factorial covariance-analysis showed that differences in the initial hostility-syndrome and catatonic-syndrome scores are predictors for a syndrom-relevant differential dosage per group." | 2.65 | [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)]. ( Fararuni, M; Heinrich, K; Lehmann, E; Quadbeck, H; Tegeler, J, 1980) |
| "/day) versus fixed standard dosage (20 mg." | 2.64 | High vs standard dosage fluphenazine HCL in acute schizophrenia. ( Donlon, PT; Meadow, A; Tupin, JP; Wahba, M, 1978) |
| "Schizophrenia is thought to be the psychiatric diagnosis the most frequently associated with TD." | 1.39 | [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. ( Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I, 2013) |
| "A male patient with chronic paranoid schizophrenia developed delusions of substitution that were of abrupt onset and short duration." | 1.28 | Delusions of substitution and diabetes mellitus. ( Khanna, N; Khanna, R, 1991) |
| " The mean dosage of the drug was 25-50 mg per 3-4 weeks." | 1.27 | [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary]. ( Abramova, LI; Gushanskiĭ, EL, 1986) |
| "The results of treating 251 therapeutically resistant patients with paranoid schizophrenia by moditen-depo, its combination with other psychotic drugs or leponex was compared." | 1.26 | [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex]. ( Aranovich, AG; Gamburg, AL; Kotel'kevich, IuN; Omorokov, BM; Rasniuk, VA, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (80.39) | 18.7374 |
| 1990's | 7 (13.73) | 18.2507 |
| 2000's | 1 (1.96) | 29.6817 |
| 2010's | 2 (3.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umino, M | 1 |
| Kobayashi, R | 1 |
| Nisijima, K | 1 |
| Suda, S | 1 |
| Sejil, I | 1 |
| Oumaya, A | 1 |
| Bouguerra, C | 1 |
| Mehdi, F | 1 |
| Bellaaj, R | 1 |
| Gallali, S | 1 |
| Miller, DD | 1 |
| Gamburg, AL | 1 |
| Aranovich, AG | 1 |
| Kotel'kevich, IuN | 1 |
| Omorokov, BM | 1 |
| Rasniuk, VA | 1 |
| Balon, R | 1 |
| Kabesh, Ia | 1 |
| Papezhova, G | 1 |
| Bartels, M | 1 |
| Riffel, B | 1 |
| Stöhr, M | 1 |
| Müller, P | 1 |
| Hartman, N | 1 |
| Brizer, D | 1 |
| Eth, S | 1 |
| Waldmann, KD | 1 |
| Neumann, J | 1 |
| Gattaz, WF | 1 |
| Riederer, P | 1 |
| Reynolds, GP | 1 |
| Gattaz, D | 1 |
| Beckmann, H | 1 |
| Regan, WA | 1 |
| Gaby, N | 1 |
| Lefkowitz, D | 1 |
| Israel, JR | 1 |
| McCarron, MM | 1 |
| Boettger, ML | 1 |
| Peck, JJ | 1 |
| Russell, N | 1 |
| Landmark, J | 1 |
| Merskey, H | 1 |
| Turpin, T | 1 |
| Lehmann, E | 1 |
| Quadbeck, H | 1 |
| Tegeler, J | 1 |
| Fararuni, M | 1 |
| Heinrich, K | 1 |
| Bechter, K | 1 |
| Harasko-van der Meer, C | 1 |
| Brücke, T | 1 |
| Wenger, S | 1 |
| Fischer, P | 1 |
| Deecke, L | 1 |
| Podreka, I | 1 |
| Buhrich, N | 1 |
| Hayman, J | 1 |
| Durst, R | 1 |
| Dorevitch, A | 1 |
| Fraenkel, Y | 1 |
| Donlon, PT | 1 |
| Meadow, A | 1 |
| Tupin, JP | 1 |
| Wahba, M | 1 |
| Wilson, LG | 1 |
| Halbreich, U | 1 |
| Assael, M | 1 |
| Marcjan, K | 1 |
| Pietruszewska, I | 1 |
| Wolak, E | 1 |
| Pfefferbaum, A | 1 |
| Berger, PA | 2 |
| De Fraites, EG | 1 |
| Davis, KL | 1 |
| Schulz, HD | 1 |
| Kluge, HH | 1 |
| Korda, W | 1 |
| Kube, B | 1 |
| Itil, TM | 1 |
| Marasa, J | 1 |
| Saletu, B | 1 |
| Davis, S | 1 |
| Mucciardi, AN | 1 |
| Marriott, P | 1 |
| Grigor, J | 1 |
| Hiep, A | 1 |
| Lanczik, M | 1 |
| Fritze, J | 1 |
| Kline, JS | 1 |
| Smith, JE | 1 |
| Ellis, HC | 1 |
| Khanna, R | 1 |
| Khanna, N | 1 |
| Berman, AL | 1 |
| Carotti, P | 1 |
| Merli, R | 1 |
| Roberts, JE | 1 |
| Edwards, JG | 1 |
| Checkley, S | 1 |
| Crammer, JL | 1 |
| Cutting, JC | 1 |
| Lader, MH | 1 |
| Murray, RM | 1 |
| Kontaxakis, VP | 1 |
| Christodoulou, GN | 1 |
| Markidis, MP | 1 |
| Havaki-Kontaxaki, BJ | 1 |
| Rampertaap, MP | 1 |
| Raines, JM | 1 |
| Greenspan, D | 1 |
| Weiden, P | 1 |
| Harrigan, M | 1 |
| Abramova, LI | 1 |
| Gushanskiĭ, EL | 1 |
| Cadieux, RJ | 1 |
| Kales, JD | 1 |
| Kales, A | 1 |
| Biever, J | 1 |
| Mann, LD | 1 |
| Molcan, J | 1 |
| Floreánová, L | 1 |
| Novotný, V | 1 |
| Polák, L | 1 |
| Rakús, A | 1 |
| Motýlová, A | 1 |
| Hollister, LE | 1 |
| Overall, JE | 1 |
| Kimbell, I | 1 |
| Pokorny, A | 1 |
| Avrutskii, GIa | 1 |
| Gurovich, IIa | 1 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Carney, MW | 1 |
| Sheffield, BF | 1 |
| Meltzer, HY | 1 |
| Sachar, EJ | 1 |
| Frantz, AG | 1 |
| Davidson, J | 1 |
| Berliner, J | 1 |
| Dubourg, GO | 1 |
| Liberman, RP | 1 |
| Davis, J | 1 |
| Moon, W | 1 |
| Moore, J | 1 |
| Tsutsul'kovskaia, MIa | 1 |
| Minsker, EI | 1 |
| Panteleeva, GP | 1 |
| Mazurskii, MB | 1 |
| Pekunova, LG | 1 |
| Sims, A | 1 |
| White, A | 1 |
1 review available for fluphenazine and Delusional Disorder
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
5 trials available for fluphenazine and Delusional Disorder
| Article | Year |
|---|---|
[Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].
Topics: Adult; Dose-Response Relationship, Drug; Female; Fluphenazine; Hostility; Humans; Male; Schizophreni | 1980 |
High vs standard dosage fluphenazine HCL in acute schizophrenia.
Topics: Acute Disease; Adult; Benztropine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doubl | 1978 |
Computerized EEG: predictor of outcome in schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Computers; Drug Resistance; Electroencephalography | 1975 |
Specific indications for different classes of phenothiazines.
Topics: Adult; Age Factors; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; | 1974 |
Research design for analyzing drug-environment-behavior interactions.
Topics: Adult; Behavior Therapy; Chlorpromazine; Environment; Evaluation Studies as Topic; Extinction, Psych | 1973 |
45 other studies available for fluphenazine and Delusional Disorder
| Article | Year |
|---|---|
Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Female; Fluphenazine; Hip; Humans; Injections, | 2017 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Rel | 2013 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fema | 2003 |
[Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Delayed-Action Preparatio | 1980 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Mal | 1982 |
[Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Flupenth | 1982 |
[What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Administration Sch | 1983 |
Ethical considerations in research on methadone in the treatment of schizophrenia.
Topics: Double-Blind Method; Ethics, Medical; Euphoria; Fluphenazine; Human Experimentation; Humans; Informe | 1984 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; S | 1984 |
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Norepinephrine; Schizophre | 1983 |
Legal lesson of the month. Force-medicating the mental patient: assault? Case in point: Goedecke v. State (602P. 2d 123-COLO.).
Topics: Colorado; Fluphenazine; Humans; Jurisprudence; Male; Patient Compliance; Schizophrenia, Paranoid | 1980 |
Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Follow-Up Studies; Humans | 1982 |
A case of neuroleptic malignant syndrome successfully treated with amantadine.
Topics: Adult; Amantadine; Consciousness Disorders; Fluphenazine; Humans; Male; Malignant Hyperthermia; Musc | 1982 |
A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
Topics: Adult; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Fluspirilene; Humans; Ma | 1982 |
[Is there a special indication for fluphenazine in therapy refractory hallucinations?].
Topics: Clozapine; Delusions; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluphenazine; | 1994 |
Two cases of long term dopamine D2 receptor blockade after depot neuroleptics.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Delayed-Action Preparations; Dopamine D2 Receptor Anta | 1993 |
Self-inflicted enucleation of both eyes.
Topics: Adult; Eye Enucleation; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Religion and P | 1994 |
Platelet dysfunction associated with clozapine therapy.
Topics: Amobarbital; Blood Cell Count; Clozapine; Delayed-Action Preparations; Diazepam; Drug Monitoring; Dr | 1993 |
Cross-cultural differences in indicators of improvement from psychosis: the case of betel nut chewing.
Topics: Adult; Areca; Cross-Cultural Comparison; Female; Fluphenazine; Humans; Mastication; Micronesia; Plan | 1979 |
"Clubbing" -- a side-effect of long-term phenothiazines treatment.
Topics: Adult; Fingers; Fluphenazine; Hand Deformities, Acquired; Humans; Long-Term Care; Male; Regional Blo | 1976 |
[Results of the use of fluphenazine in a depot preparation].
Topics: Adolescent; Adult; Bipolar Disorder; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; | 1975 |
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma.
Topics: Chlorpromazine; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Narco | 1977 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine | 1977 |
[Treatment of schizophrenic psychoses with Lyorodin].
Topics: Acute Disease; Chronic Disease; Female; Fluphenazine; Humans; Male; Parkinson Disease, Secondary; Sc | 1977 |
Letter: Flexibility in the use of fluphenazine decanoate.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Fluphenazine; Humans; Middle Aged; Schizophrenia; Sch | 1975 |
[Neuroleptic malignant syndrome--a case report].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Fluphenazine; Humans; Male; Neuroleptic Mali | 1992 |
Paranoid and nonparanoid schizophrenic processing of facially displayed affect.
Topics: Adult; Affect; Attention; Discrimination Learning; Facial Expression; Fluphenazine; Humans; Mental R | 1992 |
Delusions of substitution and diabetes mellitus.
Topics: Blood Glucose; Capgras Syndrome; Delusions; Diabetes Mellitus, Type 2; Fluphenazine; Humans; Middle | 1991 |
Case consultation. Malpractice.
Topics: Adult; Family Therapy; Fluphenazine; Humans; Male; Malpractice; Patient Compliance; Schizophrenia, P | 1989 |
[Considerations on the use of long-acting neuroleptics in a mental health center].
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Depression; Fluphenazine; | 1986 |
A case of resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Resistance; Fluphenazine; Humans; Male; Patient Readmission; Procy | 1986 |
Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
Topics: Administration, Oral; Adult; Diazepam; Drug Therapy, Combination; Fluphenazine; Humans; Injections, | 1988 |
Clonazepam in the treatment of chronic schizophrenia.
Topics: Adult; Clonazepam; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Male; Middle Ag | 1987 |
A clinical guide for diagnosing and managing patients with drug-induced dysphagia.
Topics: Aged; Deglutition Disorders; Dyskinesia, Drug-Induced; Female; Fluphenazine; Food, Formulated; Human | 1986 |
[Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
Topics: Adult; Affective Symptoms; Ambulatory Care; Antidepressive Agents; Drug Therapy, Combination; Female | 1986 |
Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.
Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Dyskinesia, Drug-Induced; Fluphenazine; | 1985 |
Psychiatric pharmacotherapy and the schizophrenic defect.
Topics: Antipsychotic Agents; Catatonia; Dibenzothiepins; Fluphenazine; Humans; Schizophrenia; Schizophrenia | 1973 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Catatonia; Depression; Female; Fluphenazine; Hospitalizati | 1973 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
Letter: Possible effects of combining phenothiazines.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Fluphenazine; Humans; Male; Middle Aged; Parkinson | 1974 |
[Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
Topics: Adult; Aged; Bipolar Disorder; Delayed-Action Preparations; Drug Evaluation; Female; Fluphenazine; H | 1974 |
Fluphenazine injections: adverse effects and treatment failures.
Topics: Adult; Fluphenazine; Humans; Male; Schizophrenia; Schizophrenia, Paranoid | 1972 |
[Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Topics: Adult; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Hum | 1973 |
Coexistence of the Capgras and de Clérambault syndromes. A case history.
Topics: Adult; Affective Symptoms; Attitude; Chlorpromazine; Delusions; Female; Fluphenazine; Humans; Mother | 1973 |